Journal
Oncotarget
Publication Date
12-29-2020
Volume
11
Issue
52
First Page
4836
Last Page
4844
Document Type
Open Access Publication
DOI
10.18632/oncotarget.27848
Rights and Permissions
Khaddour K, Dowling J, Huang J, Council M, Chen D, Cornelius L, Johanns T, Dahiya S, Ansstas G. Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation. Oncotarget. 2020 Dec 29;11(52):4836-4844. doi: 10.18632/oncotarget.27848. © 2020 Khaddour et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Citation
Khaddour, Karam; Dowling, Joshua; Huang, Jiayi; Council, Martha; Chen, David; Cornelius, Lynn; Johanns, Tanner; Dahiya, Sonika; and Ansstas, George, "Successful administration of sequential TVEC and pembrolizumab followed by temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation." Oncotarget. 11, 52. 4836 - 4844. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/10082
Addendum
